Back to User profile » Dr Olga Kaloudi
Papers published by Dr Olga Kaloudi:
Review
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Personalization of biologic therapy in patients with rheumatoid arthritis: less frequently accounted choice-driving variables
Niccoli L, Nannini C, Blandizzi C, Mantarro S, Mosca M, Di Munno O, Goletti D, Benucci M, Li Gobbi F, Cassarà E, Kaloudi O, Cantini F
Therapeutics and Clinical Risk Management 2018, 14:2097-2111
Published Date: 24 October 2018
Original Research
![Noteworthy comment: This study demonstrates that halving the dose of adalimumab used for the treatment of psoriatic arthritis (PsA) maintains drug efficacy, reduces drug exposure risks and affords cost savings. Clinical remission was achieved in a high percentage of patients with early PsA. In contrast to patients with rheumatoid arthitis, a high proportion of PsA patients maintained remission over a long-term follow-up.](assets/img/article_icons/noteworthy.png)
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Sustained maintenance of clinical remission after adalimumab dose reduction in patients with early psoriatic arthritis: a long-term follow-up study
Cantini F, Niccoli L, Cassarà E, Kaloudi O, Nannini C
Biologics: Targets and Therapy 2012, 6:201-206
Published Date: 12 July 2012